Caroline Dorsa is Director of BIOGEN INC.. Currently has a direct ownership of 31,002 shares of BIIB, which is worth approximately $4.11 Million. The most recent transaction as insider was on Jun 17, 2025, when has been sold 3,160 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31K
16.52% 3M change
16.52% 12M change
Total Value Held $4.11 Million

CAROLINE DORSA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2025
BUY
Grant, award, or other acquisition
-
3,160 Added 9.25%
31,002 Common Stock
May 02 2025
BUY
Open market or private purchase
$151,559 $122.72 p/Share
1,235 Added 4.25%
27,842 Common Stock
Jun 21 2024
BUY
Grant, award, or other acquisition
-
1,785 Added 6.29%
26,607 Common Stock
Jun 26 2023
BUY
Grant, award, or other acquisition
-
1,580 Added 5.98%
24,822 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
1,370 Added 5.57%
23,242 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
775 Added 3.42%
21,872 Common Stock

Also insider at

NTLA
Intellia Therapeutics, Inc. Healthcare
DUK
Duke Energy CORP Utilities
ILMN
ILLUMINA, INC. Healthcare
CD

Caroline Dorsa

Director
Charlotte, NC

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Track Activities on BIIB